Close

H.C. Wainwright Assumes ADMA Biologics (ADMA) at Buy

February 7, 2019 7:16 AM EST Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju assumes coverage on ADMA Biologics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login